Peng Jiang

Peng Jiang

Auto-generated profile, based on publicly available information

Peng Jiang

Jilin University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PJPeng Jiang
Peng Jiang
ZZZongzhen Zhai
Zongzhen Zhai
LZLinxian Zhao
Linxian Zhao
KZKai Zhang
Kai Zhang
LDLiwei Duan
Liwei Duan

4 December 2025 in Virulence
Verified
Journal Article
Open access
YZYing Zhang
Ying Zhang
PJPeng Jiang
Peng Jiang
JYJigang Yin
Jigang Yin
Guan ZhuGuan Zhu
Guan Zhu
Cryptosporidium is a genus of apicomplexan parasites that causes diarrheal disease in humans and animals worldwide. The primary species affecting humans are C. parvum and C. hominis, while other species may also infect humans, specially immunocompromised individuals. Infections are particularly severe in people with weakened immune systems and malnourished children in developing countries. In livestock, especially young ruminants, C. parvum leads to significant economic losses. The parasite occupies a unique epicellular niche and undergoes a complex life cycle involving both asexual and sexual stages. While the mechanisms of parasite invasion, replication, immune evasion, and tissue damage have been challenging to unravel due to earlier technical limitations and lack of genetic tools, recent advances have transformed our understanding. Innovations in genomics, transcriptomics, and molecular genetics have identified key virulence factors and clarified intricate host - parasite interactions. The parasite's secretory organelles (micronemes, rhoptries, dense granules, and small granules) play central roles by releasing molecules that facilitate host cell attachment, invasion, and modulation of host defenses. This review provides an up-to-date overview of the biology and pathogenic mechanisms of Cryptosporidium, highlighting structural features, invasion strategies, and host immune responses. It also covers recent progress in experimental models, vaccine development, and identification of new molecular targets for treatment and prevention. By synthesizing recent discoveries with previous research, this review offers a current perspective linking fundamental biology to disease outcomes and potential control strategies.

7 October 2025 in bioRxiv
Verified
Preprint
Open access
GBGracyn Y. Buenconsejo
Gracyn Y. Buenconsejo
SSSebastian Shaw
Sebastian Shaw
RXRui Xiao
Rui Xiao
ABAurelia Balestra
Aurelia Balestra
KOKeenan M. O’dea
Keenan M. O’dea
BSBoris Striepen
Boris Striepen
The parasite Cryptosporidium is a leading cause of life-threatening diarrheal disease, and effective treatment is not available. The discovery of potent anti- Cryptosporidium activity of clofazimine, offered the opportunity to repurpose a drug already used to treat leprosy and tuberculosis. However, clofazimine failed in a human trial, which was attributed to poor bioavailability. Here, we observed differential susceptibility among parasite isolates which we exploit to map the mode of action to type II NADH dehydrogenase (NDH2) in an unbiased genetic cross. Targeted genetic ablation of NDH2 resulted in profound clofazimine resistance, and biochemical studies demonstrated NDH2 mediated electron transfer to clofazimine. Through genomic analyses we uncovered heterogeneity at the NDH2 locus for C. parvum and C. hominis and widespread carriage of a conserved attenuated allele across multiple continents. This heterogeneity allows parasites genomically linked through frequent sexual recombination to adjust to changing NDH2 requirements and predisposes Cryptosporidium to evade clofazimine treatment.